Mamlok Gilad
SEC insider (Form 3/4/5 filer). CIK 0001975896. Director at Ellomay Capital Ltd. (ELLO) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 1, 2026. Located in TEL AVIV.
Companies Mamlok Gilad has filed insider reports for
- Ellomay Capital Ltd. (ELLO): Director
- Protalix BioTherapeutics, Inc. (PLX): Officer, Sr. VP and CFO
Mamlok Gilad
CIK: 0001975896
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
